Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemoprevention. Found 11 abstracts

Holmberg C, Waters EA, Whitehouse K, Daly M, McCaskill-Stevens W. My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making About Participation in the Study of Tamoxifen and Raloxifene (STAR). Med Decis Making. 2015 Jul 16;35(8):1010-22.   PMCID: 4592416
Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E-2 in Patients With Barrett's Esophagus. Gastroenterology. 2012 Oct;143(4):917-U91.   PMCID: PMC3458136
Lubet RA, Clapper ML, McCormick DL, Pereira MA, Chang WC, Steele VE, Fischer SM, Juliana MM, Grubbs CJ. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers. Oncology reports. 2012 May;27(5):1400-6.
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, MacDonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Breast Cancer Risk Reduction. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1112-46.   PMCID: not NIH funded
Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute. 2005 Nov 16;97(22):1652-62.
Gorla SR, Hou N, Acharya S, Rademaker A, Khan S, Staradub V, Morrow M. A predictive model for the development of hormone-responsive breast cancer. Annals of Surgical Oncology. 2005 Jan;12(1):48-56.
Clapper ML. Chemopreventive activity of oltipraz. Pharmacology & Therapeutics. 1998 Apr;78(1):17-27.
Clapper ML, Szarka CE. Glutathione S-transferases - biomarkers of cancer risk and chemopreventive response. Chemico-Biological Interactions. 1998 Apr 24;112:377-88.
Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. International Journal of Oncology. 1998 Apr;12(4):865-9.
Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. Journal of Mammary Gland Biology and Neoplasia. 1998 Jan;3(1):49-61.
Odwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. Journal of Clinical Investigation. 1996 Sep;98(5):1210-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemoprevention

chemoprevention cancer randomized-trial cell-proliferation carcinogenesis oltipraz male f344 rats 2-dithiol-3-thione oltipraz clinical trials animal models risk colorectal-cancer risk-factors carcinoma colon- cyclooxygenase-2 s-transferase-mu apoptosis lung-cancer susceptibility breast cancer postmenopausal women 5-(2-pyrazinyl)-4- prolactin mcf-10 BCRA2 mu detoxification enzyme inducer progesterone-receptor status hormone cancer prevention hormone-sensitive cancers randomized controlled-trial nonsteroidal antiinflammatory drugs estrogen receptor bilateral prophylactic mastectomy menopausal mechanisms in-vivo metabolite raloxifene therapy transcription LCIS methyl-1 epidemiologic characteristics tamoxifen prevention gene-expression iowa womens health dt-diaphorase progression glutathione resveratrol aromatase inhibitors induction serum-lipoproteins rat mammary carcinomas line risk reduction reducing salpingo-oophorectomy gamma-glutamylcysteine synthetase dietary modification trial replacement therapy breast-cancer bone-mineral density risk model fruit bexarotene BCRA1 aflatoxin GST individualized risk information prognostic-factors gene expression antiprogestins Targretin experimental murine colitis receptor content hormone-replacement therapy breast carcinoma lung carcinogenesis narrative interviews expression growth- genetic- colon cancer breast cancer risk rat dietary oltipraz acid cell proliferation prophylactic mastectomy NCCN Guidelines growth factors gland adenocarcinoma DT-diaphorase human hepatocytes b-1 inhibitors estrogen-plus-progestin antithrombin-iii estrogen-receptor polymerase chain-reaction NSAIDs Esophageal Cancer-Inflammation-Esophagus risk assessment ursodeoxycholic differentiation NCCN Clinical Practice Guidelines lived experiences positive cancers hot flashes surgical adjuvant breast decision making alcohol-consumption 5-(2-pyrazinyl)-4-methyl-1 lgd1069 antiestrogens polymorphism colon carcinogenesis human-leukocytes 1975 cock sj-biometrics-v31-p103 plasma-lipids pregnancy broccoli brca2 mutation carriers steroid hormones
Last updated on Wednesday, March 04, 2020